Study Testing the Biologic Activity and Safety of a Immunotherapeutic in Patients With Newly Diagnosed Advanced Stage Kidney Cancer in Combination With a Marketed Renal Cell Carcinoma Treatment

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2008
Study to investigate an anticancer cellular immunotherapeutic, AGS-003, when used in combination with sunitinib in subjects with previously untreated advanced stage RCC.
Epistemonikos ID: 4c78ee86ce842e6f7dc4c3032cb54ab4f4a15828
First added on: Jul 16, 2020